[HTML][HTML] The Robo4 cytoplasmic domain is dispensable for vascular permeability and neovascularization
Nature communications, 2016•nature.com
Vascular permeability and neovascularization are implicated in many diseases including
retinopathies and diabetic wound healing. Robo4 is an endothelial-specific transmembrane
receptor that stabilizes the vasculature, as shown in Robo4−/− mice that develop
hyperpermeability, but how Robo4 signals remained unclear. Here we show that Robo4
deletion enhances permeability and revascularization in oxygen-induced retinopathy (OIR)
and accelerates cutaneous wound healing. To determine Robo4 signalling pathways, we …
retinopathies and diabetic wound healing. Robo4 is an endothelial-specific transmembrane
receptor that stabilizes the vasculature, as shown in Robo4−/− mice that develop
hyperpermeability, but how Robo4 signals remained unclear. Here we show that Robo4
deletion enhances permeability and revascularization in oxygen-induced retinopathy (OIR)
and accelerates cutaneous wound healing. To determine Robo4 signalling pathways, we …
Abstract
Vascular permeability and neovascularization are implicated in many diseases including retinopathies and diabetic wound healing. Robo4 is an endothelial-specific transmembrane receptor that stabilizes the vasculature, as shown in Robo4−/− mice that develop hyperpermeability, but how Robo4 signals remained unclear. Here we show that Robo4 deletion enhances permeability and revascularization in oxygen-induced retinopathy (OIR) and accelerates cutaneous wound healing. To determine Robo4 signalling pathways, we generated transgenic mice expressing a truncated Robo4 lacking the cytoplasmic domain (Robo4ΔCD). Robo4ΔCD expression is sufficient to prevent permeability, and inhibits OIR revascularization and wound healing in Robo4−/− mice. Mechanistically, Robo4 does not affect Slit2 signalling, but Robo4 and Robo4ΔCD counteract Vegfr2-Y949 (Y951 in human VEGFR2) phosphorylation by signalling through the endothelial UNC5B receptor. We conclude that Robo4 inhibits angiogenesis and vessel permeability independently of its cytoplasmic domain, while activating VEGFR2-Y951 via ROBO4 inhibition might accelerate tissue revascularization in retinopathy of prematurity and in diabetic patients.
nature.com